Halo naevi and leukotrichia are strong predictors of the passage to mixed vitiligo in a subgroup of segmental vitiligo

British Journal of Dermatology

Volumn 166, Issue 3, 2012, Pages 539-544

  Ezzedine, K ^a,b   Diallo, A ^a   Leaute Labreze C ^a   Seneschal J ^a,b   Prey, S ^a,b   Ballanger, F ^a   Alghamdi, K ^c   Cario Andre M ^b   Jouary, T ^a,b   Gauthier, Y ^a,b   Taieb, A ^a,b  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID ANTIBODY;

ARTICLE; BODY SURFACE; DISEASE COURSE; FEMALE; HALO NEVUS; HUMAN; LEUKOTRICHIA; MAJOR CLINICAL STUDY; MALE; PIGMENT DISORDER; PREDICTIVE VALUE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; THYROID FUNCTION; VITILIGO;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HAIR COLOR; HAIR DISEASES; HUMANS; INFANT; MALE; MULTIVARIATE ANALYSIS; NEVUS, HALO; PROSPECTIVE STUDIES; RISK FACTORS; VITILIGO; YOUNG ADULT;

EID: 84855543465     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10709.x     Document Type: Article

References (24)

1. Spritz RA,. The genetics of generalized vitiligo and associated autoimmune diseases. Pigment Cell Res 2007; 20: 271-8. (Pubitemid 47057312)
2. Spritz RA,. The genetics of generalized vitiligo. Curr Dir Autoimmun 2008; 10: 244-57.
3. Howitz J, Brodthagen H, Schwartz M, Thomsen K,. Prevalence of vitiligo: epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol 1977; 113: 47-52. (Pubitemid 8020128)
4. Koga M,. Vitiligo: a new classification and therapy. Br J Dermatol 1977; 97: 255-61. (Pubitemid 8208167)
5. TaÃeb A, Picardo M,. Clinical practice. Vitiligo. N Engl J Med 2009; 360: 160-9.
6. Gauthier Y, Cario-André M, Taieb A,. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 2003; 16: 322-31.
7. Mulekar SV, Al Issa A, Assad M, et al. Mixed vitiligo. J Cutan Med Surg 2006; 10: 104-7. (Pubitemid 351517541)
8. Schallreuter KU, Krüger C, Rokos H, et al. Basic research confirms coexistence of acquired Blaschkolinear vitiligo and acrofacial vitiligo. Arch Dermatol Res 2007; 299: 225-30. (Pubitemid 47222918)
9. Ezzedine K, Gauthier Y, Léauté-LabrÃze C, et al. Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients. J Am Acad Dermatol 2011; 65: 965-71.
10. Van Geel N, De Lille S, Vandenhaute S, et al. Different phenotypes of segmental vitiligo based on a clinical observational study. J Eur Acad Dermatol Venereol 2011; 25: 673-8.
11. Ezzedine K, Diallo A, Léauté-LabrÃze C, et al. Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients. Br J Dermatol 2011; 165: 44-9.
12. TaÃeb A, Picardo M, VETF members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 2007; 20: 27-35. (Pubitemid 46090162)
13. TaÃeb A, Morice-Picard F, Jouary T, et al. Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non-segmental vitiligo. Pigment Cell Melanoma Res 2008; 21: 646-52.
14. Hann SK, Lee HJ,. Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol 1996; 35: 671-4. (Pubitemid 26389462)
15. Van Geel N, Speeckaert R, Lambert J, et al. Halo naevi with associated vitiligo-like depigmentations: pathogenetic hypothesis. J Eur Acad Dermatol Venereol 2011; 25: 673-8 [Epub ahead of print].
16. Barona MI, Arrunátegui A, Falabella R, Alzate A,. An epidemiologic case-control study in a population with vitiligo. J Am Acad Dermatol 1995; 33: 621-5.
17. Jouary T, Taieb A,. Halo Nevi and Vitiligo. Berlin, Heidelberg: Springer-Verlag, 2010; 61-4.
18. Ezzedine K, Diallo A, Léauté-LabrÃze C, et al. Halo nevi association in nonsegmental vitiligo influences age of onset and depigmentation pattern. Arch Dermatol 2012; (in press).
19. Van Geel N, Mollet IG, De Schepper S, et al. First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi. Pigment Cell Melanoma Res 2010; 23: 375-84.
20. Parsad D, Pandhi R, Dogra S, Kumar B,. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. J Am Acad Dermatol 2004; 50: 63-7. (Pubitemid 38095653)
21. Westgate GE, Craggs RI, Gibson WT,. Immune privilege in hair growth. J Invest Dermatol 1991; 97: 417-20.
22. Christoph T, Müller-Röver S, Audring H, et al. The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol 2000; 142: 862-73. (Pubitemid 30304594)
23. Ito T, Meyer KC, Ito N, Paus R,. Immune privilege and the skin. Curr Dir Autoimmun 2008; 10: 27-52.
24. Tobin DJ,. The cell biology of human hair follicle pigmentation. Pigment Cell Melanoma Res 2011; 24: 75-88.